Quarterly Results

FERMENTA BIOTECH LTD.

NSE : NABSE : 506414ISIN CODE : INE225B01021Industry : Pharmaceuticals & DrugsHouse : Private
BSE183.250.25 (+0.14 %)
PREV CLOSE ( ) 183.00
OPEN PRICE ( ) 184.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 11408
TODAY'S LOW / HIGH ( )181.00 186.05
52 WK LOW / HIGH ( ) 132.3214
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
989.67
569.08
824.48
1051.63
Total Expenditure
738.49
708.25
715.12
856.51
PBIDT (Excl OI)
251.18
-139.17
109.36
195.12
Other Income
25.24
18.96
20.07
11.61
Operating Profit
276.42
-120.21
129.43
206.73
Interest
51.85
36.87
47.84
63.09
Exceptional Items
NA
-74.26
NA
-90.71
PBDT
224.57
-231.34
81.58
52.93
Depreciation
63.84
59.31
59.47
61.87
Profit Before Tax
160.73
-290.65
22.11
-8.93
Tax
60.83
NA
NA
40.32
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
99.9
-290.65
22.11
-49.26
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
99.9
-290.65
22.11
-49.26
Minority Interest
-1.41
12.65
-3.79
11.81
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
98.49
-278
18.33
-37.46
Equity Capital
144.37
144.37
144.29
144.29
Face Value (IN RS)
5
5
5
5
Reserves
NA
NA
NA
NA
Calculated EPS
3.41
-9.62
0.63
-1.29
Calculated EPS (Annualised)
13.64
-38.51
2.54
-5.19
No of Public Share Holdings
11165796
11165796
11165796
11894595
% of Public Share Holdings
37.94
37.94
37.94
40.42
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
25.38
-24.45
13.26
18.55
PBIDTM%
27.93
-21.12
15.69
19.65
PBDTM%
22.69
-40.65
9.89
5.03
PBTM%
16.24
-51.07
2.68
-0.85
PATM%
10.09
-51.07
2.68
-4.68
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.